Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $11,958 | $6,373 | $8,137 | $6,321 |
| - Cash | $186 | $184 | $264 | $563 |
| + Debt | $17 | $16 | $16 | $5 |
| Enterprise Value | $11,789 | $6,204 | $7,889 | $5,763 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 50% |
| EBITDA | -$101 | -$136 | -$119 | -$109 |
| % Margin | – | – | – | -16,626.8% |
| Net Income | -$114 | -$119 | -$103 | -$86 |
| % Margin | – | – | – | -13,162.4% |
| EPS Diluted | -3.01 | -3.16 | -2.75 | -2.47 |
| % Growth | 4.7% | -14.9% | -11.3% | – |
| Operating Cash Flow | -$111 | -$110 | -$64 | -$101 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$112 | -$111 | -$65 | -$101 |